Parasitic Diseases of the Central Nervous System: The Diagnostic Challenge
April 6th 2016This article is the second in a 3-part series on parasitic diseases of the central nervous system (CNS) and highlights some of the techniques that clinicians use for the diagnosis of parasitic diseases of the CNS.
Insecticide-Treated Nets Prove to be Effective Malaria Control
April 5th 2016The findings of a new study reinforce the value of making insecticide-treated nets and indoor residual spraying of insecticides universally available—even in countries where the mosquitoes that transmit disease bite primarily outdoors.
Utilizing Whole Genome Sequencing to Combat MRSA Infections
April 4th 2016Researchers at Jiangsu University in China have demonstrated that whole genome sequencing can be used to confirm findings from traditional bacterial genotyping methods to identify outbreaks of MRSA and control nosocomial transmission.
Knowledge of Cholera Lacking in Regions Where the Disease is Most Prevalent
April 1st 2016The findings of a recent study suggest that knowledge of cholera and its symptoms is sorely lacking among female caretakers in the Indian sub-continent—despite the fact that the disease has been present in the region for centuries.
hMPV: Is This Relatively New Paramyxovirus Cause for Concern?
March 28th 2016Human metapneumovirus (hMPV), of the paramyxovirus family, was discovered in 2001. hMPV can affect people of all ages, however, older adults, children and individuals with weak immune systems are at highest risk of contracting the virus.
Researchers On the Verge of Identifying Biomarkers to Predict Dengue Disease Course
March 17th 2016An international team of researchers believes they may be on the verge of identifying biomarkers that can be used to predict disease course in dengue fever, thereby enabling clinicians to triage patients at higher risk for severe forms of the mosquito-borne infection at an earlier stage.
Hepatitis C Treatment to be Afforded to All Infected Veterans, Regardless of Stage of Disease
March 16th 2016An increase in funding from Congress, in addition to a decrease in drug prices, will allow the VA to finance medical care for all hepatitis C patients, regardless of the stage of the disease, for fiscal year 2016.